Analyst Viewpoint
Rise in prevalence of chronic obstructive pulmonary diseases (COPD) is expected to drive the extracorporeal CO2 removal market growth in the near future. Poor dietary habits and sedentary lifestyles, coupled with alcoholism and excessive smoking or chewing of tobacco, are key factors driving the susceptibility to respiratory disorders across the globe.
Increase in awareness about acute respiratory distress syndrome (ARDS) and its early detection are likely to fuel the demand for low-flow extracorporeal CO2 removal devices in the near future. Stringent quality guidelines and safety standards set for carbon dioxide removal devices are expected to offer significant extracorporeal CO2 removal market opportunities for manufacturers to develop advanced devices that comply with regulatory requirements.
Extracorporeal CO2 removal devices, as the name suggests, eliminate carbon dioxide but are not related to providing oxygenation, unlike extracorporeal membrane oxygenation (ECMO) devices. They comprise a pump console with an isolating transformer and heater. The transformer offers arteriovenous and venovenous access. Presently, technological advancements have led to the development of simpler, safer, and more routine applications such as wire-reinforced dual-lumen catheters, pumps for permitting venovenous support, and durable biocompatible membranes.
However, extracorporeal CO2 removal devices, if not used by well-trained professionals, could result in thrombus formation, bleeding, and hemolysis in lungs. Lack of skilled professionals is estimated to restrain the market value during the forecast period.
As per the National Institutes of Health, 10.3% of the global population suffers from chronic obstructive pulmonary disease (COPD). This is one of the major factors driving the growth of extracorporeal CO2 removal devices in the next few years. Advantages of these devices, apart from CO2 elimination, include vitalization of blood flow and strong support to lungs. ALung Technologies uses Hemolung for respiratory support. It has been organizing Hemolung Reference Centre Program since 2013 for hospitals worldwide. Indications for ECCO2R therapy include blood flow rates of <= 450 mL/min23. Integration with the other organ support therapies such as blood purification therapies or CRRT is required. Growing number of COPD patients is expected to accelerate the global market during the forecast period.
As per the WHO, 22% of the global population would cross 60 by the year 2050. The aging population is more prone to COPD, as age-related alterations in function and structure of the lung increase pathogenic susceptibility regarding COPD. Aging also weakens the functional and morphological resistance of the respiratory system, which results in morbidity.
Need for respiratory support to the geriatric population implies usage of extracorporeal techniques for hypercapnia management. Currently, research regarding usage of low-flow extracorporeal CO2 removal devices is being undertaken to facilitate ultra-low volume mechanical ventilation considering the sensitive age of the group treated. Growth in population aged above 60 is thus expected to propel the global market value during the forecast period.
North America holds the largest extracorporeal CO2 removal market share. This is attributed to continuous enhancement in infrastructure in the U.S., followed by higher rate of adoption of extracorporeal carbon dioxide removal devices during as well as after the pandemic era. Moreover, according to the American Lung Association, 11.7 million people in the U.S. contracted COPD in 2022.
According to the European Respiratory Journal, 9.3% of people in Europe are likely to be suffering from COPD. Moreover, as per the European Centre for Disease Prevention and Control (ECDC), 7.55 of those diagnosed with Covid-19 from August 2020 to May 2021 needed hospitalization. Acute respiratory distress syndrome (ARDS) is among the serious complications of COVID-19. Therefore, growing incidences of COPD and ARDS are expected to influence the global market outlook during the forecast period.
Rise in incidence of COPD in Australia, Japan, China, India, and Indonesia is expected to drive the extracorporeal CO2 removal industry growth in Asia Pacific during the forecast period. As per the National Institutes of Health, 16.7% of the population in China suffers from COPD, followed by Australia (14.5%).
As per the latest extracorporeal CO2 removal market analysis, key players in market are looking forward to upgrade their offerings to develop enhanced and safe extracorporeal carbon dioxide elimination technology. Leading companies are focusing on extensive R&D and approval to their pipeline offering and conduct clinical trials.
ALung Technologies Inc., XENIOS AG, Medica SpA, Estor SpA, Medtronic Plc, Getinge AB, and Aferetica s.r.l. are a few prominent entities operating in the global market.
Key players in the global extracorporeal CO2 removal market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 82.0 Mn |
| Forecast (Value) in 2031 | US$ 153.3 Mn |
| Growth Rate (CAGR) | 7.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Extracorporeal CO2 Removal Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 82.0 Mn in 2022
It is projected to expand at a CAGR of 7.1% from 2023 to 2031
Rise in incidence of chronic pulmonary obstructive diseases and increase in geriatric population
In terms of end-user, the hospitals segment held largest share in 2022
North America is estimated to dominate in the next few years
ALung Technologies Inc., XENIOS AG, Medica SpA, Estor SpA, Medtronic Plc, Getinge AB, and Aferetica s.r.l.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Extracorporeal CO2 Removal Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Extracorporeal CO2 Removal Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Extracorporeal CO2 Machines
6.3.2. Disposables
6.3.3. Gas Exchange Units
6.3.4. Access Cannulas
6.4. Market Attractiveness, by Product
7. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
7.3.2. Acute Respiratory Distress Syndrome (ARDS)
7.3.3. Bridge to Transplant
7.3.4. Others
7.3.5. 7.4 Market Attractiveness, by Application
8. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Access Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Access Type, 2017–2031
8.3.1. Venovenous
8.3.2. Arteriovenous
8.4. Market Attractiveness, by Access Type
9. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospital
9.3.2. Surgical Centers
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Extracorporeal CO2 Removal Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Extracorporeal CO2 Machines
11.2.2. Disposables
11.2.3. Gas Exchange Units
11.2.4. Access Cannulas
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Chronic Obstructive Pulmonary Disease (COPD)
11.4.2. Acute Respiratory Distress Syndrome (ARDS)
11.4.3. Bridge to Transplant
11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value Forecast, by Access Type, 2017–2031
11.6.1. Venovenous
11.6.2. Arteriovenous
11.7. Market Attractiveness, by Access Type
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospital
11.8.2. Surgical Centers
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Application
11.11.3. By Access Type
11.11.4. By End-user
11.11.5. By Country
12. Europe Extracorporeal CO2 Removal Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Extracorporeal CO2 Machines
12.2.2. Disposables
12.2.3. Gas Exchange Units
12.2.4. Access Cannulas
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Chronic Obstructive Pulmonary Disease (COPD)
12.4.2. Acute Respiratory Distress Syndrome (ARDS)
12.4.3. Bridge to Transplant
12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by Access Type, 2017–2031
12.6.1. Venovenous
12.6.2. Arteriovenous
12.7. Market Attractiveness, by Access Type
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospital
12.8.2. Surgical Centers
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Application
12.11.3. By Access Type
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Extracorporeal CO2 Removal Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Extracorporeal CO2 Machines
13.2.2. Disposables
13.2.3. Gas Exchange Units
13.2.4. Access Cannulas
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Chronic Obstructive Pulmonary Disease (COPD)
13.4.2. Acute Respiratory Distress Syndrome (ARDS)
13.4.3. Bridge to Transplant
13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by Access Type, 2017–2031
13.6.1. Venovenous
13.6.2. Arteriovenous
13.7. Market Attractiveness, by Access Type
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospital
13.8.2. Surgical Centers
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Application
13.11.3. By Access Type
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Extracorporeal CO2 Removal Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Extracorporeal CO2 Machines
14.2.2. Disposables
14.2.3. Gas Exchange Units
14.2.4. Access Cannulas
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Chronic Obstructive Pulmonary Disease (COPD)
14.4.2. Acute Respiratory Distress Syndrome (ARDS)
14.4.3. Bridge to Transplant
14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by Access Type, 2017–2031
14.6.1. Venovenous
14.6.2. Arteriovenous
14.7. Market Attractiveness, by Access Type
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospital
14.8.2. Surgical Centers
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Application
14.11.3. By Access Type
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Extracorporeal CO2 Removal Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Extracorporeal CO2 Machines
15.2.2. Disposables
15.2.3. Gas Exchange Units
15.2.4. Access Cannulas
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Chronic Obstructive Pulmonary Disease (COPD)
15.4.2. Acute Respiratory Distress Syndrome (ARDS)
15.4.3. Bridge to Transplant
15.4.4. Others
15.5. Market Attractiveness, by Application
15.6. Market Value Forecast, by Access Type, 2017–2031
15.6.1. Venovenous
15.6.2. Arteriovenous
15.7. Market Attractiveness, by Access Type
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospital
15.8.2. Surgical Centers
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Application
15.11.3. By Access Type
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Alung Technologies Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. XENIOS AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medica SpA
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Estor SpA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Medtronic plc
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Getinge AB
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Aferetica s.r.l.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
List of Tables
Table 01: Global Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 05: Global Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 08: North America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 09: North America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 10: North America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 13: Europe Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Europe Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 15: Europe Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Asia Pacific Extracorporeal CO2Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Asia Pacific Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 20: Asia Pacific Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Latin America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Latin America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 25: Latin America Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 28: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 29: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by Access Type, 2017–2031
Table 30: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Extracorporeal CO2 Removal Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Extracorporeal CO2 Removal Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Extracorporeal CO2 Removal Market Value Share, by Product, 2022
Figure 04: Global Extracorporeal CO2 Removal Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Extracorporeal CO2 Removal Market Value Share, by Application, 2022
Figure 06: Global Extracorporeal CO2 Removal Market Revenue (US$ Mn), by Access Type, 2022
Figure 07: Global Extracorporeal CO2 Removal Market Value Share, by Access Type, 2022
Figure 08: Global Extracorporeal CO2 Removal Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Extracorporeal CO2 Removal Market Value Share, by End-user, 2022
Figure 10: Global Extracorporeal CO2 Removal Market Value Share, by Region, 2022
Figure 11: Global Extracorporeal CO2 Removal Market Value (US$ Mn) Forecast, 2022–2031
Figure 12: Global Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 13: Global Extracorporeal CO2 Removal Market Attractiveness Analysis, by Product, 2023-2031
Figure 14: Global Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 15: Global Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023-2031
Figure 16: Global Extracorporeal CO2 Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 17: Global Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023-2031
Figure 18: Global Extracorporeal CO2 Removal Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Extracorporeal CO2 Removal Market Value Share, by End-user, 2022
Figure 20: Global Extracorporeal CO2 Removal Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Extracorporeal CO2 Removal Market Attractiveness Analysis, by Region, 2022-2031
Figure 22: North America Extracorporeal CO2 Removal Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Extracorporeal CO2 Removal Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: North America Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 27: North America Extracorporeal CO2 Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 28: North America Extracorporeal CO2 Removal Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Product, 2023–2031
Figure 30: North America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023–2031
Figure 31: North America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023–2031
Figure 32: North America Extracorporeal CO2 Removal Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Extracorporeal CO2 Removal Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Extracorporeal CO2 Removal Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Extracorporeal CO2 Removal Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 37: Europe Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 38: Europe Extracorporeal CO2 Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 39: Europe Extracorporeal CO2 Removal Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Extracorporeal CO2 Removal Market Attractiveness Analysis, by Product, 2023–2031
Figure 41: Europe Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023–2031
Figure 42: Europe Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023–2031
Figure 43: Europe Extracorporeal CO2 Removal Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Extracorporeal CO2 Removal Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Extracorporeal CO2 Removal Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Extracorporeal CO2 Removal Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 48: Asia Pacific Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 49: Asia Pacific Extracorporeal CO2 Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 50: Asia Pacific Extracorporeal CO2 Removal Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Extracorporeal CO2 Removal Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Asia Pacific Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Asia Pacific Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023–2031
Figure 54: Asia Pacific Extracorporeal CO2 Removal Market Attractiveness Analysis, by End-user, 2023–2031
Figure 55: Latin America Extracorporeal CO2 Removal Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Extracorporeal CO2 Removal Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 59: Latin America Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 60: Latin America Extracorporeal CO2Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 61: Latin America Extracorporeal CO2 Removal Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Extracorporeal CO2Removal Market Attractiveness Analysis, by Product, 2023–2031
Figure 63: Latin America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023–2031
Figure 64: Latin America Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023–2031
Figure 65: Latin America Extracorporeal CO2 Removal Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Extracorporeal CO2 Removal Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Extracorporeal CO2 Removal Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Extracorporeal CO2 Removal Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Extracorporeal CO2 Removal Market Value Share Analysis, by Product, 2022 and 2031
Figure 70: Middle East & Africa Extracorporeal CO2 Removal Market Value Share Analysis, by Application, 2022 and 2031
Figure 71: Middle East & Africa Extracorporeal CO2 Removal Market Value Share Analysis, by Access Type, 2022 and 2031
Figure 72: Middle East & Africa Extracorporeal CO2 Removal Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Extracorporeal CO2 Removal Market Attractiveness Analysis, by Product, 2023–2031
Figure 74: Middle East & Africa Extracorporeal CO2 Removal Market Attractiveness Analysis, by Application, 2023–2031
Figure 75: Middle East & Africa Extracorporeal CO2 Removal Market Attractiveness Analysis, by Access Type, 2023–2031
Figure 76: Middle East & Africa Extracorporeal CO2 Removal Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Extracorporeal CO2 Removal Market
